Key Points Dynavax Technologies (NASDAQ:DVAX) exceeded analyst expectations in Q2 2025, reporting GAAP revenue of $95.4 million and GAAP diluted EPS of $0.14. HEPLISAV-B, Dynavax's two-dose adult ...

Jerome Adams, the U.S. Surgeon General under President Trump's first term, is criticizing his administration's cuts to mRNA vaccine research.

Moderna (MRNA) skyrocketed to fame during the pandemic, delivering one of the first mRNA-based Covid-19 vaccines and quickly ...

The US vaccines market, valued at $29.5B in 2024, is projected to reach $60B by 2033, at a CAGR of 8.2%. Key growth drivers include rising infectious diseases and biotech advancements. Comprehensive ...

Sanofi’s shift to immunology, AI-driven R&D, and strong pipeline offset risks from patent cliffs and legal issues. See why ...

Kennedy wants to rework the U.S. program for compensating Americans injured by vaccines. The plan has long been a target of ...

This week, U.S. Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic, canceled $500 million in government-funded ...

Apple and Trump detail $100 billion U.S. spending expansion: Here's what to know Brandon Blackstock, Kelly Clarkson's ...

The US Department of Health and Human Services led by Robert F Kennedy Jr. has announced to slash $500 million in funding for ...

Uptake rates for most childhood vaccinations have been dropping in Canada for years; in the case of MMR, they fall way short ...

President Donald Trump’s plans for 100% tariffs on computer chips that aren’t made in the U.S. are stoking confusion among ...